{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T21:08:23Z","timestamp":1788988103229,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020412","name":"Humanitas Research Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.autrev.2026.104171","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:25:28Z","timestamp":1788222328000},"page":"104171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The placebo effect in psoriatic arthritis"],"prefix":"10.1016","volume":"25","author":[{"given":"Francesca","family":"Motta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Cannistr\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Tonutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Selmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2026.104171_bb0005","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s40744-016-0029-z","article-title":"Psoriatic arthritis and burden of disease: patient perspectives from the population-based multinational assessment of psoriasis and psoriatic arthritis (MAPP) survey","volume":"3","author":"Kavanaugh","year":"2016","journal-title":"Rheumatol Ther"},{"key":"10.1016\/j.autrev.2026.104171_bb0010","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s40744-025-00758-6","article-title":"The relationship between metabolic syndrome and pain catastrophizing in psoriatic arthritis","volume":"12","author":"Currado","year":"2025","journal-title":"Rheumatol Ther"},{"key":"10.1016\/j.autrev.2026.104171_bb0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","article-title":"EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update","volume":"76","author":"Agca","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2026.104171_bb0020","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1002\/acr.23171","article-title":"Incidence and prevalence of cardiovascular risk factors among patients with rheumatoid arthritis, psoriasis, or psoriatic arthritis","volume":"69","author":"Radner","year":"2017","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.autrev.2026.104171_bb0025","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1093\/rheumatology\/keaa780","article-title":"Comorbidities, pain and fatigue in psoriatic arthritis, psoriasis and healthy controls: a clinical cohort study","volume":"60","author":"Ballegaard","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2026.104171_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ncl.2025.08.001","article-title":"Placebo response and placebo effect: what is the difference?","volume":"44","author":"Benedetti","year":"2026","journal-title":"Neurol Clin"},{"key":"10.1016\/j.autrev.2026.104171_bb0035","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1186\/s13063-021-05454-8","article-title":"Placebo response and effect in randomized clinical trials: meta-research with focus on contextual effects","volume":"22","author":"Hafli\u00f0ad\u00f3ttir","year":"2021","journal-title":"Trials"},{"key":"10.1016\/j.autrev.2026.104171_bb0040","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3899\/jrheum.190008","article-title":"Placebo response in rheumatoid arthritis clinical trials","volume":"47","author":"Bechman","year":"2020","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2026.104171_bb0045","doi-asserted-by":"crossref","first-page":"5647","DOI":"10.1113\/JP271322","article-title":"Teaching neurons to respond to placebos","volume":"594","author":"Benedetti","year":"2016","journal-title":"J Physiol"},{"key":"10.1016\/j.autrev.2026.104171_bb0050","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1136\/ard.2008.092015","article-title":"The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials","volume":"67","author":"Zhang","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2026.104171_bb0055","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.35060","article-title":"Placebo response to oral administration in osteoarthritis clinical trials and its associated factors: a model-based meta-analysis","volume":"5","author":"Wen","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.autrev.2026.104171_bb0060","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/acr.25212","article-title":"Predictors of placebo response to local (intra-articular) therapy in osteoarthritis: an individual participant data meta-analysis","volume":"76","author":"Yu","year":"2024","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.autrev.2026.104171_bb0065","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.13196","article-title":"Assessment of placebo response in objective and subjective outcome measures in rheumatoid arthritis clinical trials","volume":"3","author":"Vollert","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.autrev.2026.104171_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2024.103318","article-title":"Clinical correlates of lifetime and current comorbidity patterns in autoimmune and inflammatory diseases","volume":"149","author":"H\u00e4ssler","year":"2024","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2026.104171_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2025.103501","article-title":"Elderly-onset systemic sclerosis defines a distinct clinical subset: analysis from the SPRING registry of the Italian Society for Rheumatology","volume":"157","author":"Tonutti","year":"2025","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2026.104171_bb0080","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.jaad.2024.03.058","article-title":"Psoriatic arthritis: a comprehensive review for the dermatologist part I: epidemiology, comorbidities, pathogenesis, and diagnosis","volume":"92","author":"Perez-Chada","year":"2025","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2026.104171_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2024.103187","article-title":"Autoimmune diseases and female-specific cancer risk: a systematic review and meta-analysis","volume":"144","author":"Fischer","year":"2024","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2026.104171_bb0090","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1080\/1744666X.2020.1740593","article-title":"Metabolic syndrome and psoriatic arthritis: considerations for the clinician","volume":"16","author":"Caso","year":"2020","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.autrev.2026.104171_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146991","article-title":"Cardiovascular comorbidities relate more than others with disease activity in rheumatoid arthritis","volume":"11","author":"Crepaldi","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2026.104171_bb0100","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/BOR.0000000000001023","article-title":"Navigating the complexity of pain in psoriatic arthritis and axial spondyloarthritis","volume":"36","author":"Mease","year":"2024","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2026.104171_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2025.103394","article-title":"Sex differences in biomarkers and biologic mechanisms in psoriatic diseases and spondyloarthritis","volume":"152","author":"Dang","year":"2025","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2026.104171_bb0110","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fnins.2019.00160","article-title":"Does sex\/gender play a role in placebo and nocebo effects? Conflicting evidence from clinical trials and experimental studies","volume":"13","author":"Enck","year":"2019","journal-title":"Front Neurosci"},{"key":"10.1016\/j.autrev.2026.104171_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14207348","article-title":"The role of oxytocin and sex in analgesic placebo-response: exploratory analysis from a sham randomized clinical trial in chronic back-pain patients","volume":"14","author":"Mendelson-Keypur","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.autrev.2026.104171_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002570","article-title":"Brain connectivity predicts placebo response across chronic pain clinical trials","volume":"14","author":"T\u00e9treault","year":"2016","journal-title":"PLoS Biol"},{"key":"10.1016\/j.autrev.2026.104171_bb0125","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1097\/j.pain.0000000000000333","article-title":"Increasing placebo responses over time in U.S. clinical trials of neuropathic pain","volume":"156","author":"Tuttle","year":"2015","journal-title":"Pain"},{"key":"10.1016\/j.autrev.2026.104171_bb0130","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s40261-020-00887-6","article-title":"Factors influencing placebo responses in rheumatoid arthritis clinical trials: a meta-analysis of randomized, double-blind, placebo-controlled studies","volume":"40","author":"Nagai","year":"2020","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.autrev.2026.104171_bb0135","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1186\/s13075-014-0470-8","article-title":"Nociceptive neurons detect cytokines in arthritis","volume":"16","author":"Schaible","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2026.104171_bb0140","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/acr.25694","article-title":"Beyond inflammation: why understanding the brain matters in inflammatory arthritis","volume":"78","author":"Kelleher","year":"2026","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.autrev.2026.104171_bb0145","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2025-005785","article-title":"Using ultrasound to define inflammatory and non-inflammatory phenotypes in difficult-to-treat psoriatic arthritis","volume":"11","author":"Zabotti","year":"2025","journal-title":"RMD Open"},{"key":"10.1016\/j.autrev.2026.104171_bb0150","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41584-020-00541-7","article-title":"Persistent inflammatory and non-inflammatory mechanisms in refractory rheumatoid arthritis","volume":"17","author":"Buch","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2026.104171_bb0155","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41584-025-01329-3","article-title":"Consensus definitions of complex-to-manage and treatment-refractory psoriatic arthritis: a GRAPPA initiative","volume":"22","author":"Proft","year":"2026","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2026.104171_bb0160","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-21179-3","article-title":"Meta-analysis of neural systems underlying placebo analgesia from individual participant fMRI data","volume":"12","author":"Zunhammer","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2026.104171_bb0165","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1749-6632.2009.04424.x","article-title":"Neurobiological mechanisms of placebo responses","volume":"1156","author":"Zubieta","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2026.104171_bb0170","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1038\/s41467-020-19767-w","article-title":"Parabrachial nucleus circuit governs neuropathic pain-like behavior","volume":"11","author":"Sun","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2026.104171_bb0175","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/s41586-024-07816-z","article-title":"Neural circuit basis of placebo pain relief","volume":"632","author":"Chen","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2026.104171_bb0180","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/brain\/awaf307","article-title":"Brain signatures of nociplastic pain: fibromyalgia index and descending modulation at population level","volume":"149","author":"Kelleher","year":"2026","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2026.104171_bb0185","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/art.37761","article-title":"Association of brain functional magnetic resonance activity with response to tumor necrosis factor inhibition in rheumatoid arthritis","volume":"65","author":"Rech","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2026.104171_bb0190","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1093\/cercor\/bhy188","article-title":"The functional role of large-scale brain network coordination in placebo-induced anxiolysis","volume":"29","author":"Meyer","year":"2019","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.autrev.2026.104171_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23084196","article-title":"Psycho-neuro-endocrine-immunological basis of the placebo effect: potential applications beyond pain therapy","volume":"23","author":"Ortega","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2026.104171_bb0200","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/ar2555","article-title":"Randomized controlled trial design in rheumatoid arthritis: the past decade","volume":"11","author":"Strand","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2026.104171_bb0205","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1136\/annrheumdis-2021-221807","article-title":"Impact of pre-existing background therapy on placebo responses in randomised controlled clinical trials of rheumatoid arthritis","volume":"81","author":"Kerschbaumer","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2026.104171_bb0210","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/art.43302","article-title":"Global recruiting patterns and placebo response rates in clinical trials of psoriatic arthritis and plaque psoriasis","volume":"78","author":"Kerschbaumer","year":"2026","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2026.104171_bb0215","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1093\/rheumatology\/keab774","article-title":"Placebo response in psoriatic arthritis clinical trials: a systematic review and meta-analysis","volume":"61","author":"Erre","year":"2022","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2026.104171_bb0220","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000509295","article-title":"Placebo response in phase 3 trials of systemic therapies for moderate-to-severe plaque psoriasis: a systematic review and meta-analysis","volume":"237","author":"Ambikaibalan","year":"2021","journal-title":"Dermatology"},{"key":"10.1016\/j.autrev.2026.104171_bb0225","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3390\/jcm12020429","article-title":"Clinical trials in chronic arthritic diseases with underestimated impact of placebo effects on study size calculation","volume":"12","author":"Richetti","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.autrev.2026.104171_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2025.103494","article-title":"The concept of severity in psoriatic arthritis: a scoping review of the literature","volume":"157","author":"Lubrano","year":"2025","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2026.104171_bb0235","doi-asserted-by":"crossref","first-page":"e716","DOI":"10.1016\/S2665-9913(23)00264-3","article-title":"Sex-related differences in patient characteristics, and efficacy and safety of advanced therapies in randomised clinical trials in psoriatic arthritis: a systematic literature review and meta-analysis","volume":"5","author":"Eder","year":"2023","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.autrev.2026.104171_bb0240","first-page":"159","article-title":"Depression and anxiety in a real-world psoriatic arthritis longitudinal study: should we focus more on patients\u2019 perception?","volume":"41","author":"Gialouri","year":"2023","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2026.104171_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.ard.2026.06.021","article-title":"Influence of national socioeconomic status on treatment retention and disease activity in psoriatic arthritis and axial spondyloarthritis: evidence over 2 years in 13 European countries","author":"Michelsen","year":"2026","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2026.104171_bb0250","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.ard.2026.05.013","article-title":"Composite outcome measures that successfully differentiate active treatments from placebo in psoriatic arthritis trials: a GRAPPA-OMERACT systematic review and network meta-analysis","volume":"85","author":"Annfeldt","year":"2026","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2026.104171_bb0255","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMoa2022516","article-title":"Trial of upadacitinib and adalimumab for psoriatic arthritis","volume":"384","author":"McInnes","year":"2021","journal-title":"N Engl J Med"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997226001850?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997226001850?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:27:51Z","timestamp":1788985671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997226001850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":51,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S1568997226001850"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2026.104171","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The placebo effect in psoriatic arthritis","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2026.104171","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104171"}}